Similar articles

• Differential regulation of the c-MYC P1 and P2 promoters in the absence of functional tumor suppressors: implications for mechanisms of deregulated MYC transcription.

  Marcu KB, Patel AJ, Yang Y. Marcu KB, et al. Curr Top Microbiol Immunol. 1997;224:47-56. doi: 10.1007/978-3-642-60801-8_4. Curr Top Microbiol Immunol. 1997. PMID: 9308227 Review. No abstract available.
• Triplex forming ability of a c-myc promoter element predicts promoter strength.

  Firulli AB, Maibenco DC, Kinniburgh AJ. Firulli AB, et al. Arch Biochem Biophys. 1994 Apr;310(1):236-42. doi: 10.1006/abbi.1994.1162. Arch Biochem Biophys. 1994. PMID: 8161210
• Analysis of c-Myc and Max binding to the c-myc promoter: evidence that autosuppression occurs via an indirect mechanism.

  Buckle RS, Méchali M. Buckle RS, et al. Oncogene. 1995 Mar 16;10(6):1249-55. Oncogene. 1995. PMID: 7700652
• DNA conformation, topology, and the regulation of c-myc expression.

  Levens D, Duncan RC, Tomonaga T, Michelotti GA, Collins I, Davis-Smyth T, Zheng T, Michelotti EF. Levens D, et al. Curr Top Microbiol Immunol. 1997;224:33-46. doi: 10.1007/978-3-642-60801-8_3. Curr Top Microbiol Immunol. 1997. PMID: 9308226 Review. No abstract available.
• Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.

  Roussel MF, Davis JN, Cleveland JL, Ghysdael J, Hiebert SW. Roussel MF, et al. Oncogene. 1994 Feb;9(2):405-15. Oncogene. 1994. PMID: 8290253